The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4873-4880

  Sodhi, A ^a   Montaner, S ^a   Patel, V ^a   Zohar, M ^a   Bais, C ^a   Mesri, E A ^a   Gutkind, J S ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VASCULOTROPIN; VIRUS PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; ENZYME INDUCTION; HERPES VIRUS; HYPOXIA; KAPOSI SARCOMA; MALIGNANT TRANSFORMATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; WOUND HEALING;

3T3 CELLS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COS CELLS; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; ENZYME INDUCTION; ENZYME INHIBITORS; FLAVONOIDS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMIDAZOLES; LYMPHOKINES; MAP KINASE KINASE 6; MAP KINASE KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CHEMOKINE; RESPONSE ELEMENTS; SARCOMA, KAPOSI; THIAZOLES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VIRAL PROTEINS;

EID: 0034282553     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Angiogenesis in cancer, vascular, rheumatoid and other disease
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Time-dependent vascular regression and permeability changes in established human xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody
4. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: Effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts
5. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
6. The biology of vascular endothelial growth factor
7. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
8. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
9. 2-dependent degradation domain via the ubiquitin-proteasome pathway
10. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
11. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1
12. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability
13. Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1
14. V-SRC induces expression of hypoxia-inducible factor-1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
15. Establishing a link between oncogenes and tumor angiogenesis
16. p42/p44 Mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1
17. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element
18. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
19. The enigmas of Kaposi's sarcoma
20. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma
21. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
22. KSHV and Kaposi's sarcoma: The end of the beginning?
23. Kaposi's sarcoma-associated herpesvirus
24. Trans-formation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
25. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
26. Inflammatory reactivation and angiogenicity of Kaposi's sarcoma-associated herpesvirus/HHV8: A missing link in pathogenesis of acquired immunodeficiency syndrome-associated Kaposi's sarcoma
27. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
28. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation
29. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein coupled receptor
30. Transgenic expression of chemokine receptor encoded by HHV8 induces an angioproliferative disease resembling Kaposi's sarcoma
31. Viral G protein-coupled receptor, and Kaposi's neoplasia. A model of paracrine carcinogenesis?
32. The mitogen-activated protein kinase signal transduction pathway
33. Cell growth control by G protein-coupled receptors: From signal transduction to signal integration
34. G-protein-coupled receptors and their regulation: Activation of the MAP kinase signaling pathway by G-protein-coupled receptors
35. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
36. Activation of hypoxia-inducible factor-1. Definition of regulatory domains within the α subunit
37. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway
38. 2-terminal kinase, p38s, and extracellular signal-regulated kinase 5
39. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway
40. Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension
41. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
42. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2
43. Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system
44. Transcriptional regulation by extracellular signals: Mechanisms and specificity
45. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
46. P.D. 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
47. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
48. Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases
49. Antiangiogenic tumour therapy: Will it work?
50. Targeting AIDS-Kaposis's sarcoma
51. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma
52. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells
53. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis